299 related articles for article (PubMed ID: 24466340)
1. Histone deacetylase inhibitors selectively target homology dependent DNA repair defective cells and elevate non-homologous endjoining activity.
Smith S; Fox J; Mejia M; Ruangpradit W; Saberi A; Kim S; Choi Y; Oh S; Wang Y; Choi K; Li L; Hendrickson EA; Takeda S; Muller M; Myung K
PLoS One; 2014; 9(1):e87203. PubMed ID: 24466340
[TBL] [Abstract][Full Text] [Related]
2. Increasing CRISPR/Cas9-mediated homology-directed DNA repair by histone deacetylase inhibitors.
Li G; Zhang X; Wang H; Liu D; Li Z; Wu Z; Yang H
Int J Biochem Cell Biol; 2020 Aug; 125():105790. PubMed ID: 32534122
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of DNA double strand break repair and chromosome aberration formation.
Iliakis G; Wang H; Perrault AR; Boecker W; Rosidi B; Windhofer F; Wu W; Guan J; Terzoudi G; Pantelias G
Cytogenet Genome Res; 2004; 104(1-4):14-20. PubMed ID: 15162010
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitors decrease NHEJ both by acetylation of repair factors and trapping of PARP1 at DNA double-strand breaks in chromatin.
Robert C; Nagaria PK; Pawar N; Adewuyi A; Gojo I; Meyers DJ; Cole PA; Rassool FV
Leuk Res; 2016 Jun; 45():14-23. PubMed ID: 27064363
[TBL] [Abstract][Full Text] [Related]
5. Non-homologous end joining, but not homologous recombination, enables survival for cells exposed to a histone deacetylase inhibitor.
Yaneva M; Li H; Marple T; Hasty P
Nucleic Acids Res; 2005; 33(16):5320-30. PubMed ID: 16177181
[TBL] [Abstract][Full Text] [Related]
6. The controlling role of ATM in homologous recombinational repair of DNA damage.
Morrison C; Sonoda E; Takao N; Shinohara A; Yamamoto K; Takeda S
EMBO J; 2000 Feb; 19(3):463-71. PubMed ID: 10654944
[TBL] [Abstract][Full Text] [Related]
7. Alternative-NHEJ is a mechanistically distinct pathway of mammalian chromosome break repair.
Bennardo N; Cheng A; Huang N; Stark JM
PLoS Genet; 2008 Jun; 4(6):e1000110. PubMed ID: 18584027
[TBL] [Abstract][Full Text] [Related]
8. Class I histone deacetylase inhibitors inhibit the retention of BRCA1 and 53BP1 at the site of DNA damage.
Fukuda T; Wu W; Okada M; Maeda I; Kojima Y; Hayami R; Miyoshi Y; Tsugawa K; Ohta T
Cancer Sci; 2015 Aug; 106(8):1050-6. PubMed ID: 26053117
[TBL] [Abstract][Full Text] [Related]
9. Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells.
Takata M; Sasaki MS; Sonoda E; Morrison C; Hashimoto M; Utsumi H; Yamaguchi-Iwai Y; Shinohara A; Takeda S
EMBO J; 1998 Sep; 17(18):5497-508. PubMed ID: 9736627
[TBL] [Abstract][Full Text] [Related]
10. Rad18 and Rnf8 facilitate homologous recombination by two distinct mechanisms, promoting Rad51 focus formation and suppressing the toxic effect of nonhomologous end joining.
Kobayashi S; Kasaishi Y; Nakada S; Takagi T; Era S; Motegi A; Chiu RK; Takeda S; Hirota K
Oncogene; 2015 Aug; 34(33):4403-11. PubMed ID: 25417706
[TBL] [Abstract][Full Text] [Related]
11. CDK-mediated Yku80 Phosphorylation Regulates the Balance Between Non-homologous End Joining (NHEJ) and Homologous Directed Recombination (HDR).
Carballar R; Martínez-Láinez JM; Samper B; Bru S; Bállega E; Mirallas O; Ricco N; Clotet J; Jiménez J
J Mol Biol; 2020 Dec; 432(24):166715. PubMed ID: 33217428
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair.
Lee JH; Choy ML; Ngo L; Foster SS; Marks PA
Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14639-44. PubMed ID: 20679231
[TBL] [Abstract][Full Text] [Related]
13. DNA damage response factors from diverse pathways, including DNA crosslink repair, mediate alternative end joining.
Howard SM; Yanez DA; Stark JM
PLoS Genet; 2015 Jan; 11(1):e1004943. PubMed ID: 25629353
[TBL] [Abstract][Full Text] [Related]
14. Genetic steps of mammalian homologous repair with distinct mutagenic consequences.
Stark JM; Pierce AJ; Oh J; Pastink A; Jasin M
Mol Cell Biol; 2004 Nov; 24(21):9305-16. PubMed ID: 15485900
[TBL] [Abstract][Full Text] [Related]
15. Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci.
Munshi A; Tanaka T; Hobbs ML; Tucker SL; Richon VM; Meyn RE
Mol Cancer Ther; 2006 Aug; 5(8):1967-74. PubMed ID: 16928817
[TBL] [Abstract][Full Text] [Related]
16. Chloroethylnitrosourea-induced cell death and genotoxicity: cell cycle dependence and the role of DNA double-strand breaks, HR and NHEJ.
Nikolova T; Hennekes F; Bhatti A; Kaina B
Cell Cycle; 2012 Jul; 11(14):2606-19. PubMed ID: 22751442
[TBL] [Abstract][Full Text] [Related]
17. Identification of genotoxic compounds using isogenic DNA repair deficient DT40 cell lines on a quantitative high throughput screening platform.
Nishihara K; Huang R; Zhao J; Shahane SA; Witt KL; Smith-Roe SL; Tice RR; Takeda S; Xia M
Mutagenesis; 2016 Jan; 31(1):69-81. PubMed ID: 26243743
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity.
Munshi A; Kurland JF; Nishikawa T; Tanaka T; Hobbs ML; Tucker SL; Ismail S; Stevens C; Meyn RE
Clin Cancer Res; 2005 Jul; 11(13):4912-22. PubMed ID: 16000590
[TBL] [Abstract][Full Text] [Related]
19. Biochemical evidence for Ku-independent backup pathways of NHEJ.
Wang H; Perrault AR; Takeda Y; Qin W; Wang H; Iliakis G
Nucleic Acids Res; 2003 Sep; 31(18):5377-88. PubMed ID: 12954774
[TBL] [Abstract][Full Text] [Related]
20. Suberoylanilide hydroxamic acid (SAHA) enhances olaparib activity by targeting homologous recombination DNA repair in ovarian cancer.
Konstantinopoulos PA; Wilson AJ; Saskowski J; Wass E; Khabele D
Gynecol Oncol; 2014 Jun; 133(3):599-606. PubMed ID: 24631446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
